Authors
Elizabeth Berry, MD, FAAD, is an associate professor of dermatology and the director of the Multidisciplinary Melanoma Clinic and the Pigmented Lesions Clinic at Oregon Health and Science University.
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
5
